Vericel Corp. | Key People and Executives
Dominick C. Colangelo
President, Chief Executive Officer & Director
Alan L. Rubino
Independent Director
Paul K. Wotton
Independent Director
Steven C. Gilman
Independent Director
Kevin F. McLaughlin
Independent Director
Heidi Hagen
Independent Director
Dominick C. Colangelo
President, Chief Executive Officer & Director
Daniel R. Orlando
Chief Operating Officer
Gerard J. Michel
Chief Financial & Accounting Officer
Jonathan Mark Hopper
Chief Medical Officer
David Recker
Chief Medical Officer
Roland DeAngelis
Vice President-Commercial Operations
Heidi Hassen
Senior Director-Human Resources
Michael Halpin
SVP-Quality & Regulatory Affairs
Jacquelyn Fahey Sandell
Vice President & General Counsel
Alan L. Rubino
Independent Director
Paul Kevin Wotton
Independent Director
Steven C. Gilman
Independent Director
Kevin F. McLaughlin
Independent Director
Heidi M. Hagen
Independent Director
| Address |
64 Sidney Street
Cambridge Massachusetts 02139
United States
|
|
Employees
|
- |
| Website |
http://www.vcel.com |
| Updated |
07/08/2019 |
| Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio include MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. |
